Health Tech Capitol | Exact Sciences starts scouting for a third lab site, CEO Kevin Conroy says
16741
post-template-default,single,single-post,postid-16741,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Exact Sciences starts scouting for a third lab site, CEO Kevin Conroy says

04 May Exact Sciences starts scouting for a third lab site, CEO Kevin Conroy says

Posted at 08:46h in Uncategorized by
0 Likes

Exact Sciences Corp. hasn’t finished building its second big laboratory building to process Cologuard tests for colorectal cancer but the Madison cancer diagnostics company already is planning for lab No. 3.

And, in an unrelated move, Exact’s stock price topped $100 per share this week for the first time.

Exact has “begun evaluating potential sites to open a new lab,” CEO and chairman Kevin Conroy told a conference call with financial analysts this week.

Conroy said the third site would be used for the company’s future products, all of which are still in research and development.

Read more at the Wisconsin State Journal

No Comments

Sorry, the comment form is closed at this time.